Evidence map›Paper›PMID 24360576›Full record

ArticleBiomaterials2014

Embedded multicellular spheroids as a biomimetic 3D cancer model for evaluating drug and drug-device combinations.

Kristie M Charoen, Brian Fallica, Yolonda L Colson, Muhammad H Zaman, Mark W Grinstaff

Abstract read
In one paragraph

Article in Biomaterials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Exploring bone-tumor interactions through 3DJournal of bone oncology · 2025
    Review
  9. Article
  10. Biomechanical Aspects in Bone Tumor Engineering.Tissue engineering. Part B, Reviews · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. A photothermal driven chemotherapy for the treatment of metastatic melanoma.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  16. Review
  17. Cancer 3D Models for Metallodrug Preclinical Testing.International journal of molecular sciences · 2023
    Review
  18. Review
  19. Cell morphology best predicts tumorigenicity and metastasisbioRxiv : the preprint server for biology · 2023
    Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kristie M CharoenDepartment of Biomedical Engineering, Boston University, Boston, MA 02215, USA.
Brian FallicaDepartment of Biomedical Engineering, Boston University, Boston, MA 02215, USA.
Yolonda L ColsonDivision of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA 02215, USA.
Muhammad H ZamanDepartment of Biomedical Engineering, Boston University, Boston, MA 02215, USA. Electronic address: zaman@bu.edu.
Mark W GrinstaffDepartment of Biomedical Engineering, Boston University, Boston, MA 02215, USA; Department of Chemistry, Boston University, Boston, MA 02215, USA. Electronic address: mgrin@bu.edu.

Funding

TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Translational Research in BiomaterialsT32EB006359 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI MARK W. GRINSTAFF, Michelle H Teplensky · 2009 to 2026
$4.2M
Boston University Cross-Disciplinary Training in Nanotechnology for CancerR25CA153955 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI FALLER, DOUGLAS V, GOLDBERG, BENNETT B · 2010 to 2014
$2.1M
Flexible, Conformal, Polymeric Films for Lung Resection MarginsR01CA149561 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI COLSON, YOLONDA L, GRINSTAFF, MARK W. · 2011 to 2014
$1.4M
NCI NIH HHS R01 CA149561NCI NIH HHS R25 CA153955NIBIB NIH HHS T32 EB006359NIBIB NIH HHS T32EB006359NIGMS NIH HHS T32 GM008541
6 · The paper itself

Abstract

Multicellular aggregates of cells, termed spheroids, are of interest for studying tumor behavior and for evaluating the response of pharmacologically active agents. Spheroids more faithfully reproduce the tumor macrostructure found in vivo compared to classical 2D monolayers. We present a method for embedding spheroids within collagen gels followed by quantitative and qualitative whole spheroid and single cell analyses enabling characterization over the length scales from molecular to macroscopic. Spheroid producing and embedding capabilities are demonstrated for U2OS and MDA-MB-231 cell lines, of osteosarcoma and breast adenocarcinoma origin, respectively. Finally, using the MDA-MB-231 tumor model, the chemotherapeutic response between paclitaxel delivery as a bolus dose, as practiced in the clinic, is compared to delivery within an expansile nanoparticle. The expansile nanoparticle delivery route provides a superior outcome and the results mirror those observed in a murine xenograft model. These findings highlight the synergistic beneficial results that may arise from the use of a drug delivery system, and the need to evaluate both drug candidates and delivery systems in the research and preclinical screening phases of a new cancer therapy development program.

Indexed as

BiomimeticsEquipment and SuppliesImaging, Three-DimensionalMicrospheresAntineoplastic AgentsCell Line, TumorDrug Evaluation, PreclinicalHumansNeoplasmsAntineoplastic Agents3D cell cultureCancer modelCell migrationCollagenDrug deliverySpheroidTumor mimic

Identifiers

PMID24360576
PMCPMC3923358

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.